The effect of gabapentin on antinociceptive action of analgesics

Acta Poloniae Pharmaceutica - Drug Research

Volumn 61, Issue 5, 2004, Pages 393-400

  Pakulska, Wanda ^a   Czarnecka, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Gabapentin; Indomethacin; Interaction; Metamizol; Morphine

Indexed keywords

ANALGESIC AGENT; DIPYRONE; GABAPENTIN; INDOMETACIN; MORPHINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HOT PLATE TEST; MALE; MORPHINE TOLERANCE; MOUSE; MULTIPLE DRUG DOSE; NOCICEPTIVE STIMULATION; NONHUMAN; SINGLE DRUG DOSE; TAIL FLICK TEST;

AMINES; ANALGESICS; ANIMALS; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; DIPYRONE; DRUG INTERACTIONS; DRUG TOLERANCE; GAMMA-AMINOBUTYRIC ACID; HEAT; INDOMETHACIN; MALE; MICE; MORPHINE; PAIN; PAIN MEASUREMENT; REACTION TIME; TIME FACTORS;

EID: 13244255583     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moskowitz M.H.: Medycyna po Dyplomie 13, 36 (2004).
2. Pakulska W., Wejman I., Czarnecka E.: Acta Pol. Pharm. 60, 201 (2003).
3. Chmielewska B.: Neur. Neurochir. Pol. 34, 133, 2000.
4. Majkowski J.: in Nowe leki przeciwpadaczkowe, Jȩdrzejczak J., Zwoliński P. Eds., p. 84, Fundacja Epileptologii, Warsaw 2000.
5. Petroff O.A.C., Rothman D.L., Behar K.L., Lamoreux D.: Ann. Neurol. 39, 95 (1996).
6. Czuczwar S.J.: Neur. Neurochir. Pol. 33, 1373 (1999).
7. Oka M., Itoh Y., Wada M., Yamamoto A., Fujita T.: Pharm. Res. 20, 897 (2003).
8. Herranz J.L.: Rev. Neurol. 36, 1159 (2003).
9. Eddy W.B., Leimbach, D.: J. Pharmacol. Exp. Ther. 107, 385 (1953).
10. D'Amour F.E., Smith D.L.: J. Pharmacol. Exp. Ther. 72, 74 (1941).
11. Gumułka W.S.: in Farmakologia. Podstawy farmakoterapii, Kostowski W. Eds, p. 898, PZWL, Warsaw 2001.
12. Schönhofer P.S.: Pharmacotherapie 2, 1 (1979).
13. Rewerski W., Gumułka W.S.: in Farmakologia. Podstawy farmakoterapii, Kostowski W. Eds, p. 243, PZWL, Warsaw 2001.
14. Dobrogowski J., Wordliczek J.: in Medycyna bólu, Dobrogowski J., Wordliczek J. Eds, p. 356 PZWL, Warsaw 2004.
15. Takasaki I., Andoh T., Nojima H., Shiraki K., Kuraishi Y.: J. Pharmacol. Exp. Ther. 296, 270 (2001).
16. Field M.J., Holloman F., Mc Cleary S., Hughes J., Singh L.: Pain 80, 391 (1999).
17. Field M.J., Holloman F., Mc Cleary S., Hughes J., Singh L.: J. Pharmacol. Exp. Ther. 282, 1242 (1997).
18. Lauda Ch., Fucus P.N.: Neurosci. Lett. 290, 137 (2000).
19. Shimoyama M., Shimoyama N., Inturrisi Ch., Elliot K.J.: Pain 72, 375 (1997).
20. Pakulska W., Czarnecka E.: Pharmazie 56, 89 (2001).
21. Viletti G., Bergamaschi M., Bassani F., Bolzoni P.T., Maiorino M., Pietra C., Rondelli I., Chamiot-Clerc P., Simonato M., Barbieri M.: J. Pharmacol. Exp. Ther. 306, 804 (2003).
22. Eckhardt K., Ammon S., Hofmann U., Riebe A., Gugeler N., Mikus G.: Anesth. Analg. 91, 185 (2000).
23. Devulder J., Lambert J., Naeyaert J.M.: J. Pain Sympt. Manag. 22, 622 (2000).
24. Collier H.O.J., Francis D.L., Schneider C.: Nature 237, 220 (1972).
25. Hernandez N., Vanegas H.: Brain Res. 30, 175 (2001).
26. Tortorici V., Vanegas H.: Eur. J. Neurosci. 7, 1857 (1995).
27. Dollery C. Eds: Therapeutic Drugs, p. G2 Churchill Livingstone 1999.
28. Panocka I., Antkowiak B., Nawrocka M., Kowalczyk M.: Ból 1, 41 (2000).